InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	11.08	6.57	8.91	6.18	7.36
Short-Term Investments	0.04	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	11.12	6.61	8.96	6.22	7.41
Cash Growth	68.10%	-26.15%	43.96%	-16.03%	26.70%
Accounts Receivable	0.47	0.35	0.26	0.09	-
Other Receivables	-	-	-	-	0.01
Receivables	0.47	0.35	0.26	0.09	0.01
Inventory	0.96	1.24	1.62	2.49	-
Prepaid Expenses	0.32	0.48	0.5	0.8	0.84
Other Current Assets	-	-	-	-	0.11
Total Current Assets	12.87	8.69	11.33	9.6	8.38
Property, Plant & Equipment	0.99	1.25	0.72	0.9	0.33
Other Intangible Assets	1.62	1.78	1.95	2.11	1.06
Other Long-Term Assets	0.1	0.1	0.1	0.18	0.01
Total Assets	15.58	11.82	14.11	12.79	9.78
Accounts Payable	0.37	0.63	0.54	1.17	0.78
Accrued Expenses	1.03	0.99	1.06	1.25	1.36
Current Portion of Leases	0.44	0.32	0.38	0.4	0.08
Other Current Liabilities	0	0.04	0.02	0.5	-
Total Current Liabilities	1.84	1.97	2	3.32	2.22
Long-Term Leases	0.31	0.64	0.02	0.39	0.19
Total Liabilities	2.15	2.62	2.02	3.71	2.4
Common Stock	91.22	82.78	77.62	70.72	60.59
Additional Paid-In Capital	39.32	35.37	35.74	31.68	21.51
Retained Earnings	-117.24	-109.08	-101.4	-93.45	-74.85
Comprehensive Income & Other	0.13	0.13	0.13	0.13	0.13
Shareholders' Equity	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	15.58	11.82	14.11	12.79	9.78
Total Debt	0.74	0.96	0.39	0.79	0.27
Net Cash (Debt)	10.38	5.65	8.57	5.43	7.14
Net Cash Growth	83.62%	-34.01%	57.80%	-23.98%	29.08%
Net Cash Per Share	10.63	14.83	69.96	193.57	531.24
Filing Date Shares Outstanding	2.38	0.67	0.17	0.05	0.02
Total Common Shares Outstanding	2	0.45	0.17	0.03	0.02
Working Capital	11.03	6.72	9.33	6.28	6.16
Book Value Per Share	6.71	20.64	72.65	279.06	458.14
Tangible Book Value	11.81	7.42	10.14	6.97	6.31
Tangible Book Value Per Share	5.90	16.65	60.95	214.23	392.20
Machinery	0.43	0.47	0.48	0.25	0.07
Leasehold Improvements	-	-	-	-	0.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q